Valuation: IDEXX Laboratories, Inc.

Market Cap 41.68B 37.2B 34.57B 31.45B 59.17B 3,947B 60.23B 415B 162B 2,060B 156B 153B 6,590B P/E 2026 *
37.1x
P/E 2027 * 32.8x
Enterprise Value 42.04B 37.53B 34.88B 31.73B 59.69B 3,982B 60.77B 419B 164B 2,078B 158B 154B 6,649B EV / Sales 2026 *
8.9x
EV / Sales 2027 * 8.09x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+3.43%
1 week+8.00%
Current month+4.79%
1 month+7.38%
3 months+1.20%
6 months-6.31%
Current year-19.12%
1 week 513.1
Extreme 513.1
547.83
1 month 501.17
Extreme 501.17
547.83
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 102.45
Extreme 102.45
769.98
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Exercice

Director

6,609 0.0084%
20/08/26 Exercice

Chief Financial Officer

616 0.0008%
30/07/26 Free

Director

49 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.43%+8.00%-14.09%+28.39% 41.68B
+2.29%+6.03%-21.45%+15.20% 178B
+1.29%+11.62%-1.13%+32.64% 121B
+4.12%+6.47%-20.75%+13.71% 108B
+0.41%+1.40%-45.37%-9.38% 75.7B
+1.56%+7.62%+7.39%+80.66% 64.15B
-1.75%-0.72%+17.66%+59.66% 53.49B
+2.58%+7.55%+2.87%-25.10% 51.45B
+5.08%+4.05%+32.47%+15.12% 31.5B
+1.78%+3.16% - - 31.52B
Average +2.08%+3.28%-4.71%+23.43% 75.62B
Weighted average by Cap. +2.03%+4.09%-10.53%+22.28%

Financials

2026 *2027 *
Net sales 4.72B 4.21B 3.92B 3.56B 6.7B 447B 6.82B 47.06B 18.41B 233B 17.72B 17.34B 747B 5.14B 4.59B 4.26B 3.88B 7.3B 487B 7.43B 51.21B 20.04B 254B 19.29B 18.88B 813B
Net income 1.18B 1.05B 977M 889M 1.67B 112B 1.7B 11.74B 4.59B 58.23B 4.42B 4.33B 186B 1.31B 1.17B 1.09B 991M 1.86B 124B 1.9B 13.08B 5.12B 64.89B 4.93B 4.82B 208B
Net Debt 368M 328M 305M 278M 522M 34.85B 532M 3.67B 1.43B 18.19B 1.38B 1.35B 58.19B -97.34M -86.88M -80.75M -73.45M -138M -9.22B -141M -970M -380M -4.81B -365M -358M -15.39B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
15/10/26 $547.18 +3.43% 545,018
14/10/26 $529.01 +1.67% 824,669
13/10/26 $520.31 -0.69% 445,415
12/10/26 $523.94 +1.15% 552,787
09/10/26 $518.00 +0.95% 466,778
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
547.18USD
Average target price
701.33USD
Spread / Average Target
+28.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. IDXX Stock